Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1987 1
1989 3
1990 4
1991 4
1992 5
1993 2
1994 6
1995 12
1996 9
1997 7
1998 8
1999 5
2000 6
2001 2
2002 8
2003 12
2004 6
2005 13
2006 16
2007 7
2008 7
2009 10
2010 5
2011 5
2012 9
2013 6
2014 7
2015 6
2016 9
2017 4
2018 7
2019 9
2020 10
2021 10
2022 11
2023 11
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

249 results

Results by year

Filters applied: . Clear all
Page 1
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
Sandborn WJ, Feagan BG, D'Haens G, Wolf DC, Jovanovic I, Hanauer SB, Ghosh S, Petersen A, Hua SY, Lee JH, Charles L, Chitkara D, Usiskin K, Colombel JF, Laine L, Danese S; True North Study Group. Sandborn WJ, et al. Among authors: wolf dc. N Engl J Med. 2021 Sep 30;385(14):1280-1291. doi: 10.1056/NEJMoa2033617. N Engl J Med. 2021. PMID: 34587385 Clinical Trial.
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies.
Sandborn WJ, Vermeire S, Peyrin-Biroulet L, Dubinsky MC, Panes J, Yarur A, Ritter T, Baert F, Schreiber S, Sloan S, Cataldi F, Shan K, Rabbat CJ, Chiorean M, Wolf DC, Sands BE, D'Haens G, Danese S, Goetsch M, Feagan BG. Sandborn WJ, et al. Among authors: wolf dc. Lancet. 2023 Apr 8;401(10383):1159-1171. doi: 10.1016/S0140-6736(23)00061-2. Epub 2023 Mar 2. Lancet. 2023. PMID: 36871574 Free article. Clinical Trial.
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P; ACCENT I Study Group. Hanauer SB, et al. Among authors: wolf dc. Lancet. 2002 May 4;359(9317):1541-9. doi: 10.1016/S0140-6736(02)08512-4. Lancet. 2002. PMID: 12047962 Clinical Trial.
Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER).
Colombel JF, Ungaro RC, Sands BE, Siegel CA, Wolf DC, Valentine JF, Feagan BG, Neustifter B, Kadali H, Nazarey P, James A, Jairath V, Qasim Khan RM. Colombel JF, et al. Among authors: wolf dc. Clin Gastroenterol Hepatol. 2023 Sep 22:S1542-3565(23)00746-2. doi: 10.1016/j.cgh.2023.09.010. Online ahead of print. Clin Gastroenterol Hepatol. 2023. PMID: 37743037 Free article.
Infliximab maintenance therapy for fistulizing Crohn's disease.
Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ. Sands BE, et al. Among authors: wolf dc. N Engl J Med. 2004 Feb 26;350(9):876-85. doi: 10.1056/NEJMoa030815. N Engl J Med. 2004. PMID: 14985485 Free article. Clinical Trial.
A new paradigm for regulatory sciences.
Hilton GM, Bhuller Y, Doe JE, Wolf DC, Currie RA. Hilton GM, et al. Among authors: wolf dc. Regul Toxicol Pharmacol. 2023 Dec;145:105524. doi: 10.1016/j.yrtph.2023.105524. Epub 2023 Nov 2. Regul Toxicol Pharmacol. 2023. PMID: 37925098 Free article. Review.
Dysphagia.
Wolf DC. Wolf DC. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. Boston: Butterworths; 1990. Chapter 82. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. Boston: Butterworths; 1990. Chapter 82. PMID: 21250248 Free Books & Documents. Review.
Reply.
Wolf DC. Wolf DC. Inflamm Bowel Dis. 2016 Sep;22(9):E32. doi: 10.1097/MIB.0000000000000878. Inflamm Bowel Dis. 2016. PMID: 27542140 No abstract available.
The management of eosinophilic gastroenteritis.
Gupta N, Aggarwal A, Gupta R, Sule S, Wolf DC. Gupta N, et al. Among authors: wolf dc. Scand J Gastroenterol. 2015;50(11):1309-14. doi: 10.3109/00365521.2015.1049655. Epub 2015 Jun 1. Scand J Gastroenterol. 2015. PMID: 26027839 Review.
249 results